Although 87% experienced at least one side effect, all participants completed the 12-week study without stopping the medication
[PubMed] [Google Scholar] 264.Lacy ER, Ito S
Anat Rec 78(2):149172 Katsurada K et al (2014) Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons
confirmed an increase in skin thickness in the range of the epidermis and dermis, improved skin hydration, a significant smoothing of the skin by stimulating collagen synthesis, increased skin elasticity, a significant improvement in skin contrast, and an increased production of collagen I
Comprehensive Medical Oversight Every patient in our GLP-1 Longevity Program receives: Thorough medical evaluation and baseline testing Personalized dosing protocols based on individual needs Regular monitoring of metabolic markers Ongoing support and dose adjustments as needed Integration with lifestyle optimization strategies Minimal Side Effects with Maximum Benefits Dr